Literature DB >> 16302959

Aspects on human amyloid forms and their fibril polypeptides.

Per Westermark1.   

Abstract

Amyloid is an in vivo fibrillar substance containing a fibril protein and several additional molecules. Presently, 25 proteins have been reported as main fibril components. Why just a few proteins form amyloid in vivo is still insufficiently understood. Many fibril proteins appear as fragments of larger precursors and for some types it is not clear whether fragmentation comes before or after fibrillation. The self-assembly by amyloid proteins can be speeded up by seeding with preformed fibrils. In mice, systemic amyloidoses are transmissible by a seeding mechanism. Whether this prion-like mechanism occurs in humans is not known, but can definitely not be ruled out.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16302959     DOI: 10.1111/j.1742-4658.2005.05024.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  57 in total

Review 1.  The structural biology of protein aggregation diseases: Fundamental questions and some answers.

Authors:  David Eisenberg; Rebecca Nelson; Michael R Sawaya; Melinda Balbirnie; Shilpa Sambashivan; Magdalena I Ivanova; Anders Ø Madsen; Christian Riekel
Journal:  Acc Chem Res       Date:  2006-09       Impact factor: 22.384

Review 2.  Sulfated glycosaminoglycans in protein aggregation diseases.

Authors:  Kazuchika Nishitsuji; Kenji Uchimura
Journal:  Glycoconj J       Date:  2017-04-11       Impact factor: 2.916

3.  Role of calpain in the formation of human papillomavirus type 16 E1^E4 amyloid fibers and reorganization of the keratin network.

Authors:  Jameela Khan; Clare E Davy; Pauline B McIntosh; Deborah J Jackson; Steven Hinz; Qian Wang; John Doorbar
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

4.  Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Abeta protofibrils.

Authors:  Gernot Habicht; Christian Haupt; Ralf P Friedrich; Peter Hortschansky; Carsten Sachse; Jessica Meinhardt; Karin Wieligmann; Gerald P Gellermann; Michael Brodhun; Jürgen Götz; Karl-Jürgen Halbhuber; Christoph Röcken; Uwe Horn; Marcus Fändrich
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-27       Impact factor: 11.205

5.  A systematic screen of beta(2)-microglobulin and insulin for amyloid-like segments.

Authors:  Magdalena I Ivanova; Michael J Thompson; David Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-07       Impact factor: 11.205

6.  Ile-phe dipeptide self-assembly: clues to amyloid formation.

Authors:  Natalia Sánchez de Groot; Teodor Parella; Francesc X Aviles; Josep Vendrell; Salvador Ventura
Journal:  Biophys J       Date:  2006-12-15       Impact factor: 4.033

7.  Potential aggregation prone regions in biotherapeutics: A survey of commercial monoclonal antibodies.

Authors:  Xiaoling Wang; Tapan K Das; Satish K Singh; Sandeep Kumar
Journal:  MAbs       Date:  2009-05-29       Impact factor: 5.857

8.  Fluorescence correlation spectroscopy shows that monomeric polyglutamine molecules form collapsed structures in aqueous solutions.

Authors:  Scott L Crick; Murali Jayaraman; Carl Frieden; Ronald Wetzel; Rohit V Pappu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-30       Impact factor: 11.205

9.  New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals.

Authors:  Luigi Zecca; Chiara Bellei; Patrizia Costi; Alberto Albertini; Enrico Monzani; Luigi Casella; Mario Gallorini; Luigi Bergamaschi; Alberto Moscatelli; Nicholas J Turro; Melvin Eisner; Pier Raimondo Crippa; Shosuke Ito; Kazumasa Wakamatsu; William D Bush; Weslyn C Ward; John D Simon; Fabio A Zucca
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-06       Impact factor: 11.205

10.  Interaction of IAPP and insulin with model interfaces studied using neutron reflectometry.

Authors:  Christoph Jeworrek; Oliver Hollmann; Roland Steitz; Roland Winter; Claus Czeslik
Journal:  Biophys J       Date:  2009-02       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.